Skip to main content

Table 1 Differentially methylated CpGs for each cancer type with over 3% SETD2 mutations

From: A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us